Add to ORKGBackground: Limited quantitative data exist on the burden of chronic comorbidities in children and adolescents with type 1 diabetes (T1D). Such knowledge is necessary for the development of guidelines and prevention programs. Objectives: To determine the incidence of chronic comorbidities in children and adolescents with T1D and to compare the risks with the diabetes-free children. Methods: A population-based cohort study was conducted using the Dutch PHARMO-RLS that comprises community pharmacy dispensing records linked to hospital admissions. Insulin prescriptions were used as a proxy to identify incident cases of T1D. All patients
Background: There is a highly variable asymptomatic period of beta cell destruction prior to the cli...
AIM: This study described the incidence and prevalence of type 1 diabetes in children in The Netherl...
AIM: This study described the incidence and prevalence of type 1 diabetes in children in The Netherl...
OBJECTIVE: To determine the incidence of chronic comorbidities among children with type 1 diabetes (...
The numbers of patients with diabetes mellitus (type 1 and type 2) are increasing globally, both in ...
OBJECTIVES: To investigate the 5-yr prevalence and incidence rates of cardiovascular medication and ...
OBJECTIVES: To investigate the 5-yr prevalence and incidence rates of cardiovascular medication and ...
Objectives To determine the prevalence of type 1 diabetes mellitus (T1D) in patients with juvenile i...
Objectives To determine the prevalence of type 1 diabetes mellitus (T1D) in patients with juvenile i...
Background: There is no recent data on the epidemiology of type 1 diabetes (T1D) in Dutch children a...
A population-based cohort study was conducted in the Dutch PHARMO database to investigate prevalence...
A population-based cohort study was conducted in the Dutch PHARMO database to investigate prevalence...
BACKGROUND: There is a highly variable asymptomatic period of beta cell destruction prior to the cli...
OBJECTIVE: To assess the trends in the incidence and prevalence rates of type 1 diabetes (T1D) among...
OBJECTIVE: To assess the trends in the incidence and prevalence rates of type 1 diabetes (T1D) among...
Background: There is a highly variable asymptomatic period of beta cell destruction prior to the cli...
AIM: This study described the incidence and prevalence of type 1 diabetes in children in The Netherl...
AIM: This study described the incidence and prevalence of type 1 diabetes in children in The Netherl...
OBJECTIVE: To determine the incidence of chronic comorbidities among children with type 1 diabetes (...
The numbers of patients with diabetes mellitus (type 1 and type 2) are increasing globally, both in ...
OBJECTIVES: To investigate the 5-yr prevalence and incidence rates of cardiovascular medication and ...
OBJECTIVES: To investigate the 5-yr prevalence and incidence rates of cardiovascular medication and ...
Objectives To determine the prevalence of type 1 diabetes mellitus (T1D) in patients with juvenile i...
Objectives To determine the prevalence of type 1 diabetes mellitus (T1D) in patients with juvenile i...
Background: There is no recent data on the epidemiology of type 1 diabetes (T1D) in Dutch children a...
A population-based cohort study was conducted in the Dutch PHARMO database to investigate prevalence...
A population-based cohort study was conducted in the Dutch PHARMO database to investigate prevalence...
BACKGROUND: There is a highly variable asymptomatic period of beta cell destruction prior to the cli...
OBJECTIVE: To assess the trends in the incidence and prevalence rates of type 1 diabetes (T1D) among...
OBJECTIVE: To assess the trends in the incidence and prevalence rates of type 1 diabetes (T1D) among...
Background: There is a highly variable asymptomatic period of beta cell destruction prior to the cli...
AIM: This study described the incidence and prevalence of type 1 diabetes in children in The Netherl...
AIM: This study described the incidence and prevalence of type 1 diabetes in children in The Netherl...